OPI One Step Opiates Rapid Test (Urine)
Rapid lateral flow immunoassay for the qualitative detection of opiates in urine, used by healthcare professionals to screen for opiate exposure. CE Marked.
Product Description
This competitive lateral flow immunoassay screens for opiates in urine using morphine as the target marker. Anti-opiate antibodies coupled to colloidal gold are contained in the conjugate pad, and immobilized opiate conjugate is placed at the test line. As urine moves by capillary action, any opiate present competes with the conjugate for the limited antibody sites. When enough drug is present the labelled particles are saturated and cannot be captured, so the test line disappears. Without opiates the antibody binds the fixed conjugate and a colored test line appears. A control line confirms adequate specimen and membrane flow.
Opiates include natural products of the opium poppy such as morphine and codeine and semi-synthetic drugs such as heroin. They relieve pain through opioid receptors in the central nervous system, and repeated or higher use can cause tolerance, physical dependence and abuse. Because morphine is a major metabolite of codeine and heroin and is excreted in urine, it serves as a broad marker of exposure. A positive result does not identify the opiate, the amount or whether use was prescribed. The assay is preliminary and qualitative; confirmation by gas chromatography/mass spectrometry and physician interpretation are recommended.
Cut-off Levels
| Product Name | Cat. No. | Specimen | Cut-off | Format |
|---|---|---|---|---|
| OPI Opiates | FHC03-S3 | Urine | 300ng/ml | Strip |
| OPI Opiates | FHC03-C3 | Urine | 300ng/ml | Cassette |
Send an Inquiry
Tell us the product and quantity you need. We will reply by email with pricing, packaging and availability for the OPI One Step Opiates Rapid Test (Urine).